%A YANG Zhi-Min, LIN Yuan, CHEN Jia-Yi, WANG Hua-Ying %T New progression of lobaplatin in the treatment of gynecologic cancer %0 Journal Article %D 2014 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673-422X.2014.11.015 %P 848-851 %V 41 %N 11 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_9553.shtml} %8 2014-12-03 %X Lobaplatin is the third generation platinum anticancer drug, and has been listed for the clinical treatment of advanced breast cancer, small cell lung cancer and chronic myeloid leukemia. Studies have shown that lobaplatin as the latest third generation platinum anticancer drug, has good water solubility, broadspectrum antitumor, strong antitumor activity, no crossresistance with other platinum drugs, low toxicity and many other features. Lobaplatin has shown a clear advantage.